DAĞGEZ, M. Et Al. 2023. Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: Could it be a new marker?. International Journal of Gynecological Cancer , vol.33, no.5 , 707-712.

DAĞGEZ, M., DOLANBAY, M., AKGÜN, H., GÜLSEREN, V., Keklikcioglu, S. A., ÖZÇELİK, B., ... SERİN, İ. S.(2023). Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: Could it be a new marker?. International Journal of Gynecological Cancer , vol.33, no.5, 707-712.

DAĞGEZ, MİNE Et Al. "Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: Could it be a new marker?," International Journal of Gynecological Cancer , vol.33, no.5, 707-712, 2023

DAĞGEZ, MİNE Et Al. "Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: Could it be a new marker?." International Journal of Gynecological Cancer , vol.33, no.5, pp.707-712, 2023

DAĞGEZ, M. Et Al. (2023) . "Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: Could it be a new marker?." International Journal of Gynecological Cancer , vol.33, no.5, pp.707-712.

@article{article, author={MİNE DAĞGEZ Et Al. }, title={Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: Could it be a new marker?}, journal={International Journal of Gynecological Cancer}, year=2023, pages={707-712} }